Multidrug Resistance Mediated by MRP1 Gene Overexpression in Breast Cancer Patients

REFERENCES

• Paul D., Cowan K. H. Drug resistance in breast cancer. Breast Cancer Molecular Genetics, Pathogenesis, and Therapeutics. Humana Pres, Totowa, NJ, 481–517
   Google Scholar
• Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. H., Duncan A. M., Deeley R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 5088: 1650–1654
   Google Scholar
• Cole S. P.C., Sparks K. E., Fraser K., Loe D. W., Grant C. E., Wilson G. M., Deeley R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994; 54: 5902–5910
   PubMed Web of Science ®Google Scholar
• Tammur J., Prades C., Arnould I., Rzhetsky A., Hutchinson A., Adachi M., Schuetz J. D., Swoboda K. J., Ptacek L. J., Rosier M., Dean M., Allikmets R. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 AND ABCC12, tandemly duplicated on chromosome 16q12. Gene 2001; 273: 89–96
   PubMed Web of Science ®Google Scholar
• Hollo Z., Homolya L., Hegedus T., Sarkadi B. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Letters 1996; 383: 99–104
   PubMed Web of Science ®Google Scholar
• Gaudiano G., Koch T. H., Lo Bello M., Nuccetelli M., Ravagnan G., Serafino A., Sinibaldi-Vallebona P. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Bioch Pharm 2000; 60: 1915–1923
   PubMed Web of Science ®Google Scholar
• Nooter K., Westerman A. M., Flens M. J., Zaman G. J., Scheper R. J., van Wingerden K. E., Burger H., Oostrum R., Boersma T., Sonneveld P. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995; 1: 1301–1310
   PubMed Web of Science ®Google Scholar
• Grant C. E., Valdirmarsson G., Hipfner D. R., Almquist K. C., Cole S. P., Deeley R. G., Rapid R. N.A. Isolation without the use of commercial kits: application to small tissue samples Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357–361
   PubMed Web of Science ®Google Scholar
• Gauthier E. R., Madison S D, Michel R N. Rapid RNA isolation without the use of commercial kits: application to small tissue samples. Europ J Physiology 1997; 433: 664–668
   Web of Science ®Google Scholar
• Ferrero J. M., Etienne M. C., Formento J. L., Francoual M., Rostagno P., Peyrottes I., Ettore F., Teissier E., Leblanc-Talent P., Namer M., Milano G. Application of an original RT-PCRELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients. Br J Cancer 2000; 82: 171–177
   PubMed Web of Science ®Google Scholar
• Dexter D. W., Reddy R. K., Geles K. G., Bansal S., Myint M. A., Rogakto A., Leighton J. C., Goldstein L J. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma. Clin Cancer Res 1998; 4: 1533–1542
   PubMed Web of Science ®Google Scholar
• Baran Y., Ural A. U., Gunduz U. Cross-Resistance To Cytosine Arabinoside in Human Acute Myeloid Leukemia Cells Selected for Resistance to Vincristine. Exp Oncol 2006; 28: 163–165
   PubMedGoogle Scholar
• Baran Y., Gur B., Kaya P., Ural A. U., Avcu F., Gunduz U. Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Hemat 2007; 12(6)511–517
   PubMed Web of Science ®Google Scholar
• Wada H., Saikawa Y., Niida Y., Nishimura R., Noguchi T., Matsukawa H., Ichihara T., Koizumi S. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells. Exp Hemat 1999; 27: 99–109
   PubMed Web of Science ®Google Scholar
• Zheng H., Chen Z-S, Belinsky M. G., et al. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: Effect of polyglutamylation on MTX transport. Cancer Res 2001; 61: 7225–7232
   PubMed Web of Science ®Google Scholar
• Goldhirsch A., Wood W. C., Gelber R. D., et al. Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357–3365
   PubMed Web of Science ®Google Scholar
• Rudas M., Filipits M., Taucher S., Stranzl T., Steger G. G., Jakesz R., Pirker R., Pohl G. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. Breast Cancer Res Treat 2003; 81: 149–157
   PubMed Web of Science ®Google Scholar
• Leonessa F., Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 2003; 10: 43–73
   PubMed Web of Science ®Google Scholar
• Trock B. J., Leonessa F., Clarke R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst 1997; 89: 917–931
   PubMedGoogle Scholar